Biomarin Pharmaceutical (BMRN) Long-Term Deferred Tax (2010 - 2026)
Biomarin Pharmaceutical's Long-Term Deferred Tax came in at $888.58 million for Q2 2026, down 37.7% from $1.43 billion a year earlier and down 40.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Long-Term Deferred Tax (2010 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical's Long-Term Deferred Tax was $1.51 billion, up 1.3% from FY2024.
- Long-Term Deferred Tax carries a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
- Going back by year, Long-Term Deferred Tax was $1.49 billion in FY2024 (-3.7%), $1.55 billion in FY2023 (+2.7%), $1.51 billion in FY2022 (+3.8%) and $1.45 billion in FY2021 (+1.3%).
- The Q2 2026 figure represents the lowest quarterly Long-Term Deferred Tax since Q2 2020.
- Year-over-year, Long-Term Deferred Tax increased in three of the last eight quarters, with an average decline of 6.4%.
- The fastest year-over-year change in Long-Term Deferred Tax over five years came in Q3 2023 (growth of 4.7%), and the weakest in Q2 2026 (a decline of 37.7%).
- Business Quant data shows BMRN's Long-Term Deferred Tax at $1.5 billion (Q1 2026), $1.51 billion (Q4 2025) and $1.51 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 888.58 Mn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.51 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.49 Bn |
| Sep 30, 2024 | 1.53 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.55 Bn |
| Sep 30, 2023 | 1.52 Bn |
| Jun 30, 2023 | 1.51 Bn |
| Mar 31, 2023 | 1.51 Bn |
| Dec 31, 2022 | 1.51 Bn |
| Sep 30, 2022 | 1.46 Bn |
| Jun 30, 2022 | 1.45 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.45 Bn |
| Sep 30, 2021 | 1.45 Bn |
API Access
Biomarin Pharmaceutical Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();